Published in Open Biol on September 01, 2017
Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A (1971) 31.05
RAS is regulated by the let-7 microRNA family. Cell (2005) 30.24
The DNA-damage response in human biology and disease. Nature (2009) 17.86
Epigenetics in cancer. N Engl J Med (2008) 17.36
Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science (2007) 12.42
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med (2000) 12.34
Non-coding RNAs in human disease. Nat Rev Genet (2011) 11.40
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem (2008) 10.08
Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature (1983) 9.28
Oncogenes of RNA tumor viruses as determinants of cancer. Proc Natl Acad Sci U S A (1969) 7.69
Chromosomal instability and tumors promoted by DNA hypomethylation. Science (2003) 6.02
Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res (2007) 5.62
Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science (2004) 4.58
WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med (2013) 4.52
Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology (2009) 3.42
The role of double-strand break repair - insights from human genetics. Nat Rev Genet (2006) 3.25
Directing cancer cells to self-destruct with pro-apoptotic receptor agonists. Nat Rev Drug Discov (2008) 2.95
miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett (2008) 2.81
Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum Genet (1989) 2.80
DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett (2012) 2.69
The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review. J Inherit Metab Dis (2008) 2.46
Hypomethylation of ras oncogenes in primary human cancers. Biochem Biophys Res Commun (1983) 2.41
Metabolic pathway alterations that support cell proliferation. Cold Spring Harb Symp Quant Biol (2012) 1.83
The tumor suppressor RASSF1A in human carcinogenesis: an update. Histol Histopathol (2005) 1.76
53BP1: pro choice in DNA repair. Trends Cell Biol (2013) 1.75
The role of RASSF1A methylation in cancer. Dis Markers (2007) 1.73
Epigenetic downregulation of the DNA repair gene MED1/MBD4 in colorectal and ovarian cancer. Cancer Biol Ther (2009) 1.72
Nucleotide excision repair in eukaryotes. Cold Spring Harb Perspect Biol (2013) 1.72
The PKB/AKT pathway in cancer. Curr Pharm Des (2010) 1.67
RAD51 paralogs: roles in DNA damage signalling, recombinational repair and tumorigenesis. Semin Cell Dev Biol (2011) 1.67
HMGA2 is a driver of tumor metastasis. Cancer Res (2013) 1.66
DNA double strand break repair via non-homologous end-joining. Transl Cancer Res (2013) 1.61
Human diploid cell transformation by DNA extracted from the tumor virus SV40. Science (1969) 1.60
Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma. Am J Pathol (2004) 1.58
BRCA1 is required for postreplication repair after UV-induced DNA damage. Mol Cell (2011) 1.48
"Monoallelic germline methylation and sequence variant in the promoter of the RB1 gene: a possible constitutive epimutation in hereditary retinoblastoma". Clin Epigenetics (2016) 1.47
MicroRNA-7 inhibits the growth of human non-small cell lung cancer A549 cells through targeting BCL-2. Int J Biol Sci (2011) 1.41
BRCAness revisited. Nat Rev Cancer (2016) 1.38
miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation. Mol Cancer Res (2012) 1.38
RB1, development, and cancer. Curr Top Dev Biol (2011) 1.37
Role of mTOR signaling in tumor cell motility, invasion and metastasis. Curr Protein Pept Sci (2011) 1.37
miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6. FEBS Lett (2012) 1.27
Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics. Int J Cancer (2011) 1.27
Connections between TET proteins and aberrant DNA modification in cancer. Trends Genet (2014) 1.24
DNA methylation and cancer diagnosis. Int J Mol Sci (2013) 1.18
MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation. Oral Oncol (2011) 1.18
Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics. Cell Res (2015) 1.15
WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma. Cancer Biol Ther (2010) 1.12
Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer. Dig Dis Sci (2011) 1.11
Epigenetic inactivation of TMS1/ASC in ovarian cancer. Clin Cancer Res (2004) 1.11
DNA repair, genome stability and cancer: a historical perspective. Nat Rev Cancer (2015) 1.10
Cdk4/6 inhibition induces epithelial-mesenchymal transition and enhances invasiveness in pancreatic cancer cells. Mol Cancer Ther (2012) 1.10
Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma. Am J Pathol (1997) 1.08
Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia. Leuk Lymphoma (2013) 1.08
Combined inhibition of DNA methyltransferase and histone deacetylase restores caspase-8 expression and sensitizes SCLC cells to TRAIL. Carcinogenesis (2011) 1.07
A comprehensive DNA methylation profile of epithelial-to-mesenchymal transition. Cancer Res (2014) 1.06
Hypermethylated 14-3-3-sigma and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis. BMC Cancer (2010) 1.05
Identification of the E1A-regulated transcription factor p120 E4F as an interacting partner of the RASSF1A candidate tumor suppressor gene. Cancer Res (2004) 1.03
Hypermethylation of the gene promoter and enhancer region can regulate Fas expression and sensitivity in colon carcinoma. Cell Death Differ (2003) 1.03
MacroH2A--an epigenetic regulator of cancer. Cancer Lett (2013) 1.00
Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR. Nat Med (2015) 0.98
Growth inhibitory effects of three miR-129 family members on gastric cancer. Gene (2013) 0.98
Preliminary Notes on the Development of the Wings in Normal and Mutant Strains of Drosophila. Proc Natl Acad Sci U S A (1939) 0.98
Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication. Haematologica (2012) 0.97
Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers. Oncogene (2007) 0.96
Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma. Hum Pathol (2010) 0.94
Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines. Clin Cancer Res (2013) 0.94
Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2008) 0.93
Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer. Oncogene (2009) 0.93
γ-H2AX as a biomarker for DNA double-strand breaks in ecotoxicology. Ecotoxicol Environ Saf (2014) 0.93
Assessment of the stromal contribution to Sonic Hedgehog-dependent pancreatic adenocarcinoma. Mol Oncol (2013) 0.92
PLCD1 is a functional tumor suppressor inducing G(2)/M arrest and frequently methylated in breast cancer. Cancer Biol Ther (2010) 0.92
MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma. BMC Cancer (2012) 0.92
Expression of a large LINE-1-driven antisense RNA is linked to epigenetic silencing of the metastasis suppressor gene TFPI-2 in cancer. Nucleic Acids Res (2013) 0.91
Epigenetic inactivation of the BRCA1 interactor SRBC and resistance to oxaliplatin in colorectal cancer. J Natl Cancer Inst (2013) 0.91
Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family. Br J Haematol (2011) 0.91
Inactivation of 14-3-3 sigma by promoter methylation correlates with metastasis in nasopharyngeal carcinoma. J Cell Biochem (2009) 0.90
Metabolic consequences of oncogenic IDH mutations. Pharmacol Ther (2015) 0.90
Targeting the histone orthography of cancer: drugs for writers, erasers and readers. Br J Pharmacol (2014) 0.90
Epigenetic silencing of the human nucleotide excision repair gene, hHR23B, in interleukin-6-responsive multiple myeloma KAS-6/1 cells. J Biol Chem (2004) 0.89
5-Azacytidine: a new active agent for the treatment of acute leukemia. Blood (1973) 0.89
Epigenetic inactivation of KLF4 is associated with urothelial cancer progression and early recurrence. J Urol (2013) 0.89
Epigenetic silencing of PTPRR activates MAPK signaling, promotes metastasis and serves as a biomarker of invasive cervical cancer. Oncogene (2012) 0.89
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis. Lancet Oncol (2016) 0.89
The sonic hedgehog signaling pathway maintains the cancer stem cell self-renewal of anaplastic thyroid cancer by inducing snail expression. J Clin Endocrinol Metab (2014) 0.88
DNA demethylation by 5-aza-2-deoxycytidine treatment abrogates 17 beta-estradiol-induced cell growth and restores expression of DNA repair genes in human breast cancer cells. Cancer Lett (2011) 0.88
Epigenetic regulation of HIF-1α in renal cancer cells involves HIF-1α/2α binding to a reverse hypoxia-response element. Oncogene (2011) 0.88
DNA methylation profiling revealed promoter hypermethylation-induced silencing of p16, DDAH2 and DUSP1 in primary oral squamous cell carcinoma. Int J Med Sci (2013) 0.88
Down-regulation of Gli-1 inhibits hepatocellular carcinoma cell migration and invasion. Mol Cell Biochem (2014) 0.87
Hmga2 is required for canonical WNT signaling during lung development. BMC Biol (2014) 0.87
A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect. Nat Commun (2014) 0.87
Epigenetic inactivation and tumor suppressor activity of HAI-2/SPINT2 in gastric cancer. Int J Cancer (2010) 0.87
Epigenetic silencing of DACH1 induces the invasion and metastasis of gastric cancer by activating TGF-β signalling. J Cell Mol Med (2014) 0.87
DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant (2015) 0.87
SLFN11 inhibits checkpoint maintenance and homologous recombination repair. EMBO Rep (2015) 0.87
Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma. Oncogene (2012) 0.86
Frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal cancer. PLoS One (2012) 0.86
Promoter region methylation does not account for the frequent loss of expression of the Fas gene in colorectal carcinoma. Br J Cancer (2000) 0.86
Role of Notch signalling pathway in cancer and its association with DNA methylation. J Genet (2013) 0.86
Mutations in JMJD1C are involved in Rett syndrome and intellectual disability. Genet Med (2015) 0.80